[1]
Yancy CW,Jessup M,Bozkurt B,Butler J,Casey DE Jr,Colvin MM,Drazner MH,Filippatos GS,Fonarow GC,Givertz MM,Hollenberg SM,Lindenfeld J,Masoudi FA,McBride PE,Peterson PN,Stevenson LW,Westlake C, 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017 Aug 8 [PubMed PMID: 28455343]
[2]
Packer M,Fowler MB,Roecker EB,Coats AJ,Katus HA,Krum H,Mohacsi P,Rouleau JL,Tendera M,Staiger C,Holcslaw TL,Amann-Zalan I,DeMets DL, Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation. 2002 Oct 22 [PubMed PMID: 12390947]
[3]
Poole-Wilson PA,Swedberg K,Cleland JG,Di Lenarda A,Hanrath P,Komajda M,Lubsen J,Lutiger B,Metra M,Remme WJ,Torp-Pedersen C,Scherhag A,Skene A, Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet (London, England). 2003 Jul 5 [PubMed PMID: 12853193]
[4]
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet (London, England). 1999 Jun 12 [PubMed PMID: 10376614]
[5]
Briasoulis A,Palla M,Afonso L, Meta-analysis of the effects of carvedilol versus metoprolol on all-cause mortality and hospitalizations in patients with heart failure. The American journal of cardiology. 2015 Apr 15 [PubMed PMID: 25708861]
[6]
Fröhlich H,Zhao J,Täger T,Cebola R,Schellberg D,Katus HA,Grundtvig M,Hole T,Atar D,Agewall S,Frankenstein L, Carvedilol Compared With Metoprolol Succinate in the Treatment and Prognosis of Patients With Stable Chronic Heart Failure: Carvedilol or Metoprolol Evaluation Study. Circulation. Heart failure. 2015 Sep [PubMed PMID: 26175538]
[7]
Church KM,Henalt R,Baker E,Smith GL Jr,Brennan MT,Joseph J, Comparison of metoprolol succinate versus carvedilol in time to cardiovascular admission in a Veterans Affairs healthcare system: An observational study. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2015 Dec 1 [PubMed PMID: 26582307]
[8]
Dargie HJ, Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet (London, England). 2001 May 5 [PubMed PMID: 11356434]
[9]
Li T,Ke W,Sun P,Chen X,Belgaumkar A,Huang Y,Xian W,Li J,Zheng Q, Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis. BMJ open. 2016 May 4 [PubMed PMID: 27147389]
[10]
Chen-Scarabelli C,Saravolatz L Jr,Murad Y,Shieh WS,Qureshi W,Di Rezze J,Abrencillo R,Gardin T,Gidwani UK,Saravolatz L,Faggian G,Scarabelli TM, A critical review of the use of carvedilol in ischemic heart disease. American journal of cardiovascular drugs : drugs, devices, and other interventions. 2012 Dec 1 [PubMed PMID: 23061698]
[11]
Dunn CJ,Lea AP,Wagstaff AJ, Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders. Drugs. 1997 Jul [PubMed PMID: 9211087]
[12]
McTavish D,Campoli-Richards D,Sorkin EM, Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs. 1993 Feb [PubMed PMID: 7681374]
[13]
Feuerstein GZ,Ruffolo RR Jr, Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection. European heart journal. 1996 Apr [PubMed PMID: 8733068]